EyePoint Pharmaceuticals Inc officer Dario A Paggiarino is set to sell 66,311 shares of common stock on January 23, 2024. The shares to be sold were acquired on the same date through the exercise of stock options, with the securities obtained directly from the issuer. The transaction is a cash exercise, and the aggregate market value of the shares to be sold is approximately $1,590,137.78. This planned sale follows a three-month period where Paggiarino sold a total of 54,996 shares, grossing $1,187,034.19.

EyePoint Pharmaceuticals Inc officer Dario A Paggiarino is set to sell 66,311 shares of common stock on January 23, 2024. The shares to be sold were acquired on the same date through the exercise of stock options, with the securities obtained directly from the issuer. The transaction is a cash exercise, and the aggregate market value of the shares to be sold is approximately $1,590,137.78. This planned sale follows a three-month period where Paggiarino sold a total of 54,996 shares, grossing $1,187,034.19.